The 2013 Young Researchers Bettencourt Prize was awarded to Guillaume Canaud for his research on kidney failure.

The laureate’s research topic

Acute renal failure is associated with high mortality and an increased risk of developing chronic renal failure. Guillaume Canaud seeks to identify the molecular pathways involved in cell cycle arrest following renal aggression. These new pathways present fresh therapeutic targets and hold out hope for curtailing the progress of chronic kidney disease.

Guillaume Canaud in a few words

PhD thesis: « Progression of chronic kidney disease: role of the AKT/mTORC pathway ». Université Paris Descartes, École doctorale Génétique cellule immunologie infectiologie développement, Hôpital Necker, Paris. 

Post-doctoral project: « The role of cell proliferation in renal deterioration and regeneration ». Professor Joseph Bonventre‘s laboratory at Brigham and Women’s Hospital Renal Division, Harvard Medical School, Boston (United-States).

Ever since... 

Doctor and researcher at the Institut Necker Enfants Malades (INEM), Guillaume Canaud is now a world leader in the study of overgrowth syndromes. In 2018, he and his team discovered a game-changing drug for the treatment of Cloves syndrome.

Understanding the Mechanisms Underlying the Development of Cloves Syndrome

In 2018, Dr. Canaud’s team discovered a game-changing drug for Cloves syndrome, a rare genetic disease leading to the anarchic development of certain organs. The Foundation supports the team's fundamental research to discover the mechanisms underlying this condition.

Young Researchers Bettencourt Prize

Created in 1990, the Young Researchers Bettencourt Prize is one of the first initiatives of the Fondation Bettencourt Schueller. Until 2021, this prize was awarded each year to 14 young doctors of science or doctors of medicine, to enable them to carry out their post-doctoral stay in the best foreign laboratories. 349 young researchers were distinguished. The prize endowment was €25,000.

All the award-winners